The new Safecare Bio-Tech PROFI antigen test - 25 pieces

At a time when health monitoring and early detection are more important than ever, the new Safecare antigen tests are becoming increasingly important. These quick and simple tests make it possible to quickly detect and limit the spread of diseases. Among the various options available, the new Safecare Bio-Tech PROFI antigen test is an outstanding product.

This test comes in practical packs of 25, which are suitable for individual use as well as for larger facilities. The Safecare Bio-Tech rapid test provides clear instructions and features that make it easy for non-experts without medical expertise to perform a test. The correct interpretation of the results is crucial for personal and public health.

In this article we will explain the different aspects of the Safecare Bio-Tech PROFI antigen test in detail, including its performance, test sensitivity, frequently asked questions and quality assurance. At the end, we will answer the question of whether choosing a Safecare Bio-Tech test is worthwhile for you.

Overview of Safecare Bio-Tech rapid test

The Safecare Bio-Tech Covid-19 PROFI Antigen Rapid Test offers a fast, efficient and reliable solution for the identification of novel coronavirus infections. Each of the 25 test kits included in the scope of delivery consists of a test cassette, a disposable swab, an extraction tube with buffer and instructions for use in several languages, which provide a comprehensive overview of how to use the test. This enables a result to be obtained in just 15 to 30 minutes, using a simple human nasal swab or nasopharyngeal swab for sample collection.

With an impressive sensitivity of 97.27% and a specificity of 99.42%, the Safecare Antigen Rapid Test delivers highly reliable results. Produced in China, this test is specifically designed for the qualitative detection of SARS-CoV-2 N protein in human nasal swab samples. Another important aspect is the test's best-before date, which is set until July 2026, thus ensuring long-term availability for consumers.

How will the antigen test carried out?

The Safecare Bio-Tech COVID-19 antigen rapid test enables the rapid and reliable detection of novel coronavirus infections, regardless of whether symptoms are present or not. The accuracy of the test is based on the qualitative detection of the SARS-CoV-2 antigen using the double antibody sandwich method. This makes it possible to identify the N protein specific for the virus in human nasal swab samples. A comprehensible and careful procedure is essential to ensure reliable results when performing the test.

Step-by-step instructions for testing

The Safecare Bio-Tech COVID-19 Antigen Rapid Test is a reliable tool for detecting a possible infection with the novel coronavirus. Thanks to its simple handling and fast result display, it is suitable for professional use as well as for self-application by laypersons. Here is a short guide on how to perform the test:

1. Insert the swabInsert the disposable swab into one of your nostrils. Rotate the swab for at least 15 seconds to collect an adequate sample.
2. Transfer sample: Then insert the swab into the provided extraction tube with buffer and rotate it 8 to 10 times.
3. Squeeze the swabPull out the swab and squeeze the tube to squeeze the liquid out of the swab. Close the tube with the cap.
4. Carry out the testAdd three drops of the solution to the test cassette. Wait 10-15 minutes before reading the result.

Interpretation of the results:

• Positive: Two colored lines appear (C and T).
• Negative: One colored line appears in the control region (C).
• Invalid: No line or only one line in the test region (T).

Compliance with the steps and correct execution guarantee reliable test results. Finally, make a note of your results and seek medical advice immediately in the event of a positive result.

Interpretation of the test results

The SAFECARE BIO-TECH COVID-19 Antigen Rapid Test offers a quick and reliable method to detect a possible infection with the coronavirus. The test result is indicated by the appearance of lines on the test device and should be read after a waiting time of 10 to 15 minutes to ensure an accurate interpretation.

• Positive resultIf two lines appear - the test line (T) and the control line (C) - the result indicates the presence of the coronavirus antigen in the sample. As the sensitivity of the test is 97.04%, it is very likely that an infected person will be correctly identified.
• Negative resultA negative result is indicated when only the control line (C) is visible, which means that the antigen has not been detected. The high specificity of the test of 99.44 % minimizes the risk of false-positive results.

For the final diagnosis, these rapid test results should always be considered as a basis for further laboratory results. It is also important to continue to monitor possible symptoms and clinical performance and to consult medical personnel if necessary.

Test sensitivity and CQ/CT values

The SAFECARE BIO-TECH COVID-19 Antigen Rapid Test is characterized by a high sensitivity and reliable identification of SARS-CoV-2 antigens. With a sensitivity of around 97.04%, it is able to detect positively infected persons with a high probability. The precise determination of sensitivity is crucial to increase confidence in the test results.

The CQ or CT value (cycle-threshold value) also plays an important role in assessing the viral load and therefore the risk of infection of a person being tested. A high CT value stands for a low viral load, which indicates a lower risk of infection. A low CT value, on the other hand, indicates a high viral load and therefore an increased risk of infection. In general, a CT value of around 30 is regarded as a guideline for assessing the risk of infection.

Factors such as the viral load and associated CT values influence the reliability of the test results. It is therefore important to interpret the test results in the context of various parameters and to consult additional laboratory tests for confirmation in the event of uncertainties.

Understanding the sensitivity metrics

Sensitivity and specificity are key indicators for assessing the reliability of diagnostic tests. The sensitivity of the Safecare COVID-19 antigen rapid test is 97% according to clinical studies. This means that the test has a high probability of identifying the infection in positive individuals. A sensitivity of 96.40% also supports the test's ability to correctly identify positive infected cases.

Specificity, on the other hand, indicates how well a test can confirm negative results. With a specificity of 100%, the test would classify all non-infected persons as negative. The Safecare antigen test has a high specificity of 99%, which indicates the reliability of negative test results.

In addition to these standards, the rapid availability of the test results, usually within 10 to 15 minutes, contributes to the efficiency of the Safecare Antigen Rapid Test test. This combination of high sensitivity, high specificity and fast results supports a well-founded and prompt diagnosis.

When reading these figures, it is important to understand that no diagnostic test can offer a complete guarantee. Therefore, test results should be considered in context with other tests and laboratory results.

Impact of CQ/CT values on test reliability

In the assessment of Covid-19 rapid tests the CQ or CT value (cycle-threshold value) plays an important role. This value indicates the viral load of the person tested and has a direct impact on the reliability of the test results and on the assessment of the risk of infection. The relationship between the CT value and the viral load is explained in more detail below:

A high CT value means a lower viral load. In this case, a lower risk of infection is assumed. A low CT value indicates a higher viral load and means an increased risk of infection. The guideline value for the assessment is around 30 CT values.

It is important to note that the reliability of the rapid test results can be influenced by other factors, such as

• Type of sample collection
• Time at which the test is performed
• Quality of the test kit
• Storage of the test material

These factors can affect the test result and should always be taken into account to ensure high accuracy of the results.

Frequently asked questions (FAQs)

When using the Safecare Bio-Tech COVID-19 Antigen Rapid Test questions often arise. Here are some of the main concerns and their answers to provide clarity to users.

Frequently asked questions about use and accuracy

Users of the SAFECARE BIO-TECH COVID-19 Antigen Rapid Test benefit from a high level of accuracy that is proven by clinical test results. This rapid test offers a specificity of 99% and a sensitivity of 97%, which promises reliable test results.

Results are interpreted as follows:

• Positive result: Two colored lines appear in both the control region (C) and the test line region (T).
• Negative result: A single colored line is visible in the control region (C), but not in the test line region (T).
• Invalid result: No or only one colored line is visible in the test line region (T).

An invalid result reduces the reliability of the test and requires a new sample to be taken. The sample can be collected either via the nasopharyngeal swab or the oropharyngeal swab, based on the multilingual instructions for use included with the test kit.

For home use, ease of performance is an essential factor and, according to the instructions, the application can be performed by laypersons without prior medical knowledge. However, it should always be noted that in case of any uncertainty or to confirm test results, consultation with medical personnel or a laboratory should be sought in order to make a definitive diagnosis.

Troubleshooting for general problems

When dealing with the Safecare Bio-Tech PROFI Antigen Test there may be some common challenges. Here are troubleshooting tips to help you solve the most common problems.

Problems with sample collection:

• Make sure the nasal or oropharyngeal swab is done correctly.
• Follow the instructions for use exactly to obtain a sufficient sample.

Unclear test results:

• Check that you have read the test in the allotted time frame of 15 to 30 minutes.
• Make sure that the extraction tubes with buffer have been used correctly.

Faulty test strips:

• If the test strip is damaged or shows unusual discoloration, please use a new test from the package.

Difficulties in handling:

• The test kit should be stored at room temperature to ensure the reliability of the results.
• Follow the multilingual instructions for use, which will help you to use the test correctly.

In case of further uncertainties or difficulties, please consult medical personnel or the manufacturer. A complete diagnosis should always be made on the basis of laboratory results.

Product details and verification

The Safecare Bio-Tech Covid-19 PROFI antigen rapid test is an advanced way to detect novel coronavirus infections. This test kit contains 25 individually packaged test devices, each containing sterile disposable swabs for sample collection from either the nasopharynx or oropharynx. In addition, sample solutions are provided in special extraction tubes with caps. The detailed, multilingual instructions for use - in both German and English - explain the correct procedure for the test procedure and thus promote reliable self-application by laypersons as well as professional use.

It should be noted that, for reasons of hygiene and the need for rapid diagnosis, the Corona rapid tests, including the Safecare Bio-Tech Covid-19 PROFI Antigen Rapid Testare excluded from the right of return. This underlines the importance of informing yourself about the quality and application options before purchasing. Claiming to detect all current variants of the virus, the test is proving to be a valuable tool in the fight against the pandemic.

Standards for quality assurance

The quality and reliability of COVID-19 rapid tests are of great importance to users. The Safecare Bio-Tech COVID-19 Antigen Rapid Test meets high quality standards to ensure reliable diagnostics. According to the manufacturer, the rapid test shows a sensitivity of 97.27% with a CT value below 25, which means that it can identify almost all people who are actually infected. The specificity is 99.42%, which indicates a high degree of accuracy in identifying non-infected persons.

The quality criteria for the rapid tests are checked by the renowned Paul Ehrlich Institute (PEI). This institute evaluates whether the tests meet the minimum requirements necessary to be classified as reliable. Only tests that achieve a minimum sensitivity of 75% are considered sufficiently reliable.

In addition, the Safecare COVID-19 antigen rapid test is certified according to EN ISO 13485:2016. This certification confirms compliance with internationally recognized standards in the development of medical devices.

In summary, compliance with these quality standards ensures reliable test results for both medical staff and laypersons using the home self-test.

Quality standards at a glance:

• Sensitivity: 97.27%
• Specificity: 99.42%
• Minimum sensitivity: ≥75% (for reliability)
• Review by: Paul Ehrlich Institute (PEI)
• Certification: EN ISO 13485:2016

Certification "Made in Germany" Importance

The "Made in Germany" certification is synonymous with high-quality medical devices. It guarantees that all products sold under this seal have undergone rigorous testing and thus stands for excellent quality and safety. The certification underlines the reliability of the products, which meet the highest quality standards in terms of both manufacture and functionality. A key advantage is that customers can rely on the fast delivery of these goods produced in Germany - an aspect that is particularly important in times of the need for Covid-19 antigen rapid tests is crucial. The certification confirms the manufacturers' responsibility for customer satisfaction and underlines their commitment to providing comprehensive information material.

In short, the "Made in Germany" label serves as a promise of quality and ensures that the products are not only innovative, but also meet the high expectations of customers in terms of performance and reliability.

Customers can rely on the proven and reliable quality of products with this certification.

Conclusion: If you are interested in Safecare Bio-Tech should you choose Safecare Bio-Tech?

Choosing the right COVID-19 rapid antigen test is crucial to ensure reliable and rapid detection of the infection. The Safecare Bio-Tech rapid tests offer an impressive sensitivity of 96.40 % and a specificity of 100 %. This high precision makes the Safecare Bio-Tech COVID-19 antigen rapid test a trustworthy choice.

In addition, the rapid tests are designed for self-administration by laypersons, which makes them easy to use without medical expertise. With a response time of just 10 to 15 minutes, these tests deliver results in a time frame that is ideal for quick decisions in everyday life.

Available in a 25-piece kit at a unit price of €0.91, these rapid tests offer a cost-effective option for individuals or businesses that need to perform repeated tests. Taking all of these points into consideration, the Safecare Bio-Tech COVID-19 Antigen Rapid Test appears to be a strong choice for those looking for reliable, rapid and cost-effective testing options.

Source: istockphoto VioletaStoimenova